{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:56:05Z","timestamp":1772160965385,"version":"3.50.1"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cyto.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T20:32:02Z","timestamp":1473971522000},"page":"4-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["TNF\u03b1 in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases"],"prefix":"10.1016","volume":"101","author":[{"given":"Jonas","family":"Bystrom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.I.","family":"Clanchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher E.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pam","family":"Mangat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali S.","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizgar A.","family":"Mageed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.09.001_b0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.09.001_b0010","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.2741\/3066","article-title":"TNF: a master switch for inflammation to cancer","volume":"13","author":"Sethi","year":"2008","journal-title":"Front Biosci."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0015","first-page":"93","article-title":"Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages\/neutrophils: protective and deleterious effects","volume":"22","author":"Grivennikov","year":"2005","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.cyto.2016.09.001_b0020","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.cyto.2016.09.001_b0025","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"Kremer","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6618","key":"10.1016\/j.cyto.2016.09.001_b0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.171.3.941","article-title":"A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor\/cachectin by activated normal human T cells","volume":"171","author":"Kinkhabwala","year":"1990","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","article-title":"The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor","volume":"83","author":"Grell","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ni.3352","article-title":"SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex","volume":"17","author":"Park","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0060","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2319","article-title":"Collagen-induced arthritis in C57BL\/6 mice is associated with a robust and sustained T-cell response to type II collagen","volume":"9","author":"Inglis","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.2012.01100.x","article-title":"Regulation of NF-kappaB by deubiquitinases","volume":"246","author":"Harhaj","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2016.09.001_b0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-0-12-800147-9.00002-9","article-title":"The ubiquitin system in immune regulation","volume":"124","author":"Park","year":"2014","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.cyto.2016.09.001_b0080","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/MCB.01416-12","article-title":"Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IkappaB kinase activation","volume":"33","author":"Blackwell","year":"2013","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2303.1991.tb00407.x","article-title":"Breast carcinoma with osteoclast-like giant cells","volume":"2","author":"Stewart","year":"1991","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/febs.13597","article-title":"MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-kappaB signaling","volume":"283","author":"Elton","year":"2016","journal-title":"FEBS J."},{"issue":"17","key":"10.1016\/j.cyto.2016.09.001_b0095","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1128\/MCB.22.17.6034-6045.2002","article-title":"A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells","volume":"22","author":"He","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.3172","article-title":"The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis","volume":"16","author":"Onizawa","year":"2015","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2016.09.001_b0105","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/annrheumdis-2011-201225","article-title":"Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients","volume":"71","author":"Viatte","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrd3030","article-title":"TNF receptor 2 pathway: drug target for autoimmune diseases","volume":"9","author":"Faustman","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-kappaB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.cyto.2016.09.001_b0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.cb.06.110190.002155","article-title":"The T cell antigen receptor: insights into organelle biology","volume":"6","author":"Klausner","year":"1990","journal-title":"Annu. Rev. Cell. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0125","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.1102365","article-title":"CD3zeta-chain expression of human T lymphocytes is regulated by TNF via Src-like adaptor protein-dependent proteasomal degradation","volume":"189","author":"Ersek","year":"2012","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2016.09.001_b0130","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1182\/blood-2006-12-064170","article-title":"TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues","volume":"109","author":"Zhang","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cyto.2016.09.001_b0135","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.185.9.1573","article-title":"Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling","volume":"185","author":"Cope","year":"1997","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.140.2.531","article-title":"Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha","volume":"140","author":"Yokota","year":"1988","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1189\/jlb.0303112","article-title":"Regulation of TCR-mediated T cell activation by TNF-RII","volume":"74","author":"Aspalter","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/imm.12604","article-title":"SHARPIN controls the development of regulatory T cells","volume":"148","author":"Redecke","year":"2016","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.cyto.2016.09.001_b0155","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.autrev.2011.05.001","article-title":"Therapeutic blockade of TNF in patients with SLE-promising or crazy?","volume":"11","author":"Aringer","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0165","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.38273","article-title":"Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis","volume":"66","author":"de Hair","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2016.09.001_b0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1043-4666(03)00106-6","article-title":"Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor","volume":"22","author":"Abbas","year":"2003","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.cyto.2016.09.001_b0180","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J. Clin. Invest"},{"issue":"16","key":"10.1016\/j.cyto.2016.09.001_b0185","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1073\/pnas.97.16.9203","article-title":"T cell homeostasis in patients with rheumatoid arthritis","volume":"97","author":"Koetz","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.cyto.2016.09.001_b0190","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1084\/jem.20130252","article-title":"Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells","volume":"210","author":"Yang","year":"2013","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.cyto.2016.09.001_b0195","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0200","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar4480","article-title":"Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses","volume":"16","author":"Bishu","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.cyto.2016.09.001_b0205","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.4049\/jimmunol.166.9.5495","article-title":"Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR\/CD3 complex at the cell surface","volume":"166","author":"Isomaki","year":"2001","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0215","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3899\/jrheum.110974","article-title":"Apoptosis as a mechanism of action of tumor necrosis factor antagonists in rheumatoid arthritis","volume":"39","author":"Makrygiannakis","year":"2012","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0220","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.cyto.2016.09.001_b0225","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.1780391204","article-title":"Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis","volume":"39","author":"Dolhain","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0230","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2004.022731","article-title":"Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity","volume":"64","author":"Kawashima","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0235","first-page":"317","article-title":"T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen","volume":"19","author":"Giacomelli","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2016.09.001_b0240","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1038\/ncomms4199","article-title":"TNF-alpha blockade induces IL-10 expression in human CD4+ T cells","volume":"5","author":"Evans","year":"2014","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0245","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00296-003-0374-4","article-title":"Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis","volume":"24","author":"Pawlik","year":"2004","journal-title":"Rheumatol. Int."},{"issue":"8","key":"10.1016\/j.cyto.2016.09.001_b0250","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00296-010-1402-9","article-title":"Clonal expansions in selected TCR BV families of rheumatoid arthritis patients are reduced by treatment with the TNFalpha inhibitors etanercept and infliximab","volume":"31","author":"Pierer","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"7488","key":"10.1016\/j.cyto.2016.09.001_b0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0260","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2419","article-title":"Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept","volume":"10","author":"Koczan","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.cyto.2016.09.001_b0265","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0270","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cyto.2015.01.015","article-title":"Expression of TNFalpha membrane-bound receptors in the peripheral blood mononuclear cells (PMBC) in rheumatoid arthritis patients","volume":"73","author":"Sennikov","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.09.001_b0275","article-title":"Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in TNF responders","author":"Oswald","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cyto.2016.09.001_b0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12920-015-0100-6","article-title":"Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis","volume":"8","author":"Thomson","year":"2015","journal-title":"BMC Med. Genomics"},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2004.11.060","article-title":"Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha","volume":"128","author":"Mitoma","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2016.09.001_b0290","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000289205","article-title":"The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions","volume":"11","author":"Sfikakis","year":"2010","journal-title":"Curr. Dir. Autoimmun."},{"issue":"6154","key":"10.1016\/j.cyto.2016.09.001_b0295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/331356a0","article-title":"Tumour necrosis factor-alpha in murine autoimmune \u2019lupus\u2019 nephritis","volume":"331","author":"Jacob","year":"1988","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0300","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process","volume":"180","author":"Yang","year":"1994","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0305","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2016.09.001_b0310","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J. Exp. Med."},{"issue":"7090","key":"10.1016\/j.cyto.2016.09.001_b0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0325","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0330","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2009.11.013","article-title":"Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients","volume":"69","author":"Chen","year":"2010","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0335","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1000560","article-title":"Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells","volume":"185","author":"Kleijwegt","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2016.09.001_b0340","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/eji.201041205","article-title":"TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4\u20131BB and OX40","volume":"41","author":"Hamano","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nm.4019","article-title":"Suppressive activity of human regulatory T cells is maintained in the presence of TNF","volume":"22","author":"Zaragoza","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4018","article-title":"Reply to Suppressive activity of human regulatory T cells is maintained in the presence of TNF","volume":"22","author":"Nie","year":"2016","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0355","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/art.37831","article-title":"Editorial: quality or quantity? unraveling the role of Treg cells in rheumatoid arthritis","volume":"65","author":"Prakken","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells","volume":"35","author":"Scheinecker","year":"2010","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.cyto.2016.09.001_b0365","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.37959","article-title":"Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"49","key":"10.1016\/j.cyto.2016.09.001_b0370","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0375","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2016.09.001_b0380","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII bindin\u2013g in rheumatoid arthritis","author":"Nguyen","year":"2016","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.cyto.2016.09.001_b0385","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.4049\/jimmunol.1003868","article-title":"Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function","volume":"186","author":"Housley","year":"2011","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cyto.2016.09.001_b0390","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","article-title":"Functional human regulatory T cells fail to control autoimmune inflammation due to PKB\/c-akt hyperactivation in effector cells","volume":"118","author":"Wehrens","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2016.09.001_b0395","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.23556","article-title":"Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127 -\/low regulatory T cells in patients with active systemic lupus erythematosus","volume":"58","author":"Venigalla","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0400","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/art.20976","article-title":"MRL\/Mp CD4+, CD25- T cells show reduced sensitivity to suppression by CD4+, CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus","volume":"52","author":"Monk","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.cyto.2016.09.001_b0405","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.181.10.7350","article-title":"The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells","volume":"181","author":"Schneider","year":"2008","journal-title":"J. Immunol."},{"issue":"50","key":"10.1016\/j.cyto.2016.09.001_b0410","doi-asserted-by":"crossref","first-page":"19857","DOI":"10.1073\/pnas.0810713105","article-title":"The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors","volume":"105","author":"D\u2019Alise","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0415","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diabetes.54.5.1415","article-title":"Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells","volume":"54","author":"You","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0425","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2016.09.001_b0430","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Brief report: inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0435","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/cei.12017","article-title":"Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients","volume":"171","author":"Pesce","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0440","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0445","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1084\/jem.20111703","article-title":"Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine","volume":"209","author":"Shaw","year":"2012","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0450","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0455","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.cyto.2016.09.001_b0460","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1182\/blood-2010-03-272153","article-title":"Low-strength T-cell activation promotes Th17 responses","volume":"116","author":"Purvis","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.09.001_b0465","doi-asserted-by":"crossref","first-page":"205156","DOI":"10.1155\/2015\/205156","article-title":"Harnessing the therapeutic potential of Th17 cells","volume":"2015","author":"Bystrom","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0470","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","article-title":"Th17 cells are long lived and retain a stem cell-like molecular signature","volume":"35","author":"Muranski","year":"2011","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0475","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of Th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.cyto.2016.09.001_b0480","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0485","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis","volume":"66","author":"Kebir","year":"2009","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0490","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4049\/jimmunol.1500286","article-title":"Transmembrane TNF-TNFR2 Impairs Th17 differentiation by promoting Il2 expression","volume":"195","author":"Miller","year":"2015","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cyto.2016.09.001_b0495","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0500","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","article-title":"Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial","volume":"73","author":"McInnes","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"9999","key":"10.1016\/j.cyto.2016.09.001_b0505","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0510","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis\u2013results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cyto.2016.09.001_b0515","first-page":"2336","article-title":"A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis","volume":"31","author":"Hitchon","year":"2004","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2016.09.001_b0520","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ajpath.2015.07.017","article-title":"Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis","volume":"185","author":"Kim","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.cyto.2016.09.001_b0525","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1006\/cyto.2000.0681","article-title":"Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis","volume":"12","author":"Chabaud","year":"2000","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0530","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/1529-0131(200005)43:5<1134::AID-ANR24>3.0.CO;2-#","article-title":"Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte\/macrophages: a possible role in rheumatoid arthritis","volume":"43","author":"Jovanovic","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.30093","article-title":"Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production","volume":"63","author":"van Hamburg","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.cyto.2016.09.001_b0540","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","article-title":"IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice","volume":"22","author":"Li","year":"2015","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.cyto.2016.09.001_b0545","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5966\/sctm.2015-0179","article-title":"Soluble tumor necrosis factor receptor 1 released by skin-derived mesenchymal stem cells is critical for inhibiting Th17 cell differentiation","volume":"5","author":"Ke","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"2","key":"10.1016\/j.cyto.2016.09.001_b0550","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0555","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.0802948","article-title":"Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway","volume":"182","author":"Jacob","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2016.09.001_b0560","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","article-title":"Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells","volume":"205","author":"Notley","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.09.001_b0565","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12626","article-title":"Anti-TNF treatment increases circulating Th17 cells similarly in different types of inflammatory arthritis","author":"Hull","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.09.001_b0570","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10875-012-9774-0","article-title":"Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-alpha therapy","volume":"33","author":"Xueyi","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2016.09.001_b0575","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/annrheumdis-2011-201024","article-title":"Incomplete response of inflammatory arthritis to TNFalpha blockade is associated with the Th17 pathway","volume":"71","author":"Alzabin","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.cyto.2016.09.001_b0580","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/ar3431","article-title":"Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy","volume":"13","author":"Chen","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.cyto.2016.09.001_b0585","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.cyto.2016.09.001_b0590","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10875-015-0182-0","article-title":"Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: a possible explanation for a lack of clinical response","volume":"35","author":"Talotta","year":"2015","journal-title":"J. Clin. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616304902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616304902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T04:13:01Z","timestamp":1692504781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616304902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":118,"alternative-id":["S1043466616304902"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.09.001","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF\u03b1 in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}